RELATED PARTY TRANSACTIONS |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| RELATED PARTY TRANSACTIONS | |
| RELATED PARTY TRANSACTIONS | 8. RELATED PARTY TRANSACTIONS Consulting Agreements In 2013, Capricor entered into a Consulting Agreement with Dr. Frank Litvack, the Company’s Executive Chairman and a member of its Board of Directors, whereby Capricor agreed to pay Dr. Litvack $10,000 per month for consulting services. The agreement is terminable upon 30 days’ notice. For the three months ended March 31, 2026 and 2025, the Company paid Dr. Litvack $30,000 each period under this consulting arrangement. As of March 31, 2026 and December 31, 2025, $30,000 and $10,000 were recorded in accounts payable related to this Consulting Agreement, respectively. Commercialization and Distribution Agreements As noted above, Capricor is party to two commercialization and distribution agreements with Nippon Shinyaku, which holds more than 10% of the outstanding capital stock of Capricor Therapeutics (see Note 7 – “Collaborations, Licenses and Revenue”). There were no outstanding receivables or payables as of March 31, 2026 or December 31, 2025. |